The aim of this study was to identify by immunocytochemistry the distribution of nitric oxide synthase (NOS) in human and murine gastric epithelium. Using two different antisera specific for neuronal NOS (nNOS), we detected nNOS immunoreactivity in endocrine cells of the epithelium of the body and pyloric regions as well as in ganglion cells of the intrinsic plexi of the stomach of the three species studied. Both immunocytochemistry of contiguous sections and double immunolabeling methods showed that the nNOSimmunoreactive cells were also immunoreactive for somatostatin. Co-localization of nNOS and somatostatin has also been found in the pancreatic islets, where strong nNOS immunoreactivity appeared in scattered cells, which were pe-Literature Cited
Introduction
Nitric oxide (NO) is an endogenous molecule that plays an important role in transcellular communication (1, 2) . The first studies concerning the biological effects of NO were carried out in the cardiovascular system. More recently, biosynthesis of NO has been demonstrated in many different cell types, and there is a broad profile of biological actions, in addition to vascular effects in which NO appears to be implicated (14. NO is synthesized from L-arginine via the catalytic action of a group of enzymes, the NO synthases (NOS), that require NADPH as a co-factor and are inhibited by some analogues of L-arginine. Three distinct isoforms have been described to date: the neuronal (constitutive) NOS, the endothelial (constitutive) NOS, and the macrophage (inducible) NOS. The constitutive NOS isoforms have similar co-factor requirements, are calcium-and calmodulin-dependent and, in addition to nervous system and vascular endothelium, have been localized in several tissues such as adrenal glands, pituitary, and platelets (3-5).
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been detected in many enteric neurons (7,8), and NO may act as an inhibitory neurotransmitter (9,lo). In the gastric mucosa, there is evidence of a high content of a calcium-dependent constitutive NOS (11,12), but it is not clear which cell types are responsible for this activity. The studies carried out by Brown et al. (13) on dispersed gastric epithelial cells suggested that the mucosecretory cells are the NO-producing cells. Immunocytochemical staining for NOS was first detected in the epithelium of the rat forestomach (8). Later, a study using both immunocytochemical and NADPH-diaphorase staining showed that the brush cells of the rat gastric cardia were the only labeled cells in the epithelium (14) .
The aim of the present study was to identdy by immunocytochemistry the distribution of NOS in human and murine gastric epithelium. Because our preliminary results pointed towards the somatostatin-producing cells of the stomach as a possible source of NO, we extended our studies to the somatostatin cells of the pancreatic islets.
Materials and Methods
Three surgical specimens of human stomach with areas exhibiting no histological evidence of pathologic alterations were obtained from the Dcpartment of Pathology of the University Clinic of Navarra. Six adult Wistar rats and two adult mice were anesthesized with ether and pieces from body 339 and pyloric regions of the stomach were dissected. Part of the material was fixed in Bouin's fluid or 4% paraformaldehyde for 6-8 hr, dehydrated. and embedded in paraffin. Other fragments were fixed in Zamboni's paraformaldehyde-picric mixture for 24 hr, washed in PBS 0.1 M, pH 7.3, dehydrated with ethanol, and embedded in Epon 812.
Antisera
We used two antisera specific for neuronal NOS. One was a polyclonal antiserum against the synthetic peptide no. 53 of the cloned rat neural NOS, a kind gift from V. Riveros-Moreno and S. Moncada (Wellcome Research Labs; Beckenham. Kent, UK). The amino acid sequence of this peptide was LPLIQANGNDPELFQIPPELC, as described by Riveros-Moreno et al. (15) . The optimal dilution for the antiserum was 1:1000. The second one was a monoclonal antiserum from Transduction Laboratories (Lexington, KY) (code N31020). used at a dilution of 1:500. An antiserum against inducible NOS, also courtesy of Wellcome Research Laboratories, was also tested at dilution 1:lOOO. The specificity of this antiserum has previously been shown (16) .
Gastric endocrine cells were identified with the following antisera: polyclonal anti-somatostatin44 from Incstar ( 
Immunocytochemistry
Light Microscopy. Single immunocytochemical staining was performed by the avidin-biotin-peroxidase complex method (ABC) (17) , both on conventional paraffin-embedded sections and on semithin sections from Eponembedded material. The detailed protocol used was previously described by Martinez et al. (18), the only difference being that the peroxidase activity was revealed in 0.03% 3,3'-diaminobenzidine (DAB) in 0.1 M sodium acetatelacetic buffer acid, pH 6.0, containing 2.5% nickel ammonium sulfate, 0.2% b-D-glucose, 0.04% ammonium chloride, and 0.001% glucose oxidase (19) . The specificity of the antisera was tested with absorption controls with homologous and heterologous antigens: the synthetic peptide no. 53 and somatostatin, code S-9129, from Sigma (St Louis, MO), at different concentrations of 1-0.1 nmol of antigenlml of optimally diluted antiserum Double immunostaining for nNOS and somatostatin was carried out by simultaneous avidin-biotin-peroxidase (ABC) and alkaline phosphatase-anti-alkaline phosphatase (APAAP) (20) techniques. Peroxidase activity was developed with DAB and nickel enhancement as explained above, giving a black endproduct. Alkaline phosphatase was revealed with naphthol AS-TR and new fuchsin to give a red endproduct (21) . When nNOS and somatostatin immunoreactivities co-localized in the same cells, a dark purple color was observed.
Electron Microscopy. Thin sections from Epon-embedded human material were mounted on nickel grids, incubated for l hr and l% normal goat serum in gold buffer (Tris-HC1-buffered saline 0.05 M, pH 7.2; 0.15 M CINa, with 1% bovine serum albumin and 0.050/0 sodium azide), and then incubated in the polyclonal anti-nNOS, diluted 1:100, overnight at 4'C. Subsequent passages, all at room temperature, included rinses in gold buffer, incubation for 1 hr with the gold-labeled secondary antibody (goat anti-rabbit 20-nm gold conjugate, diluted 1:20; Bio Cell Research Laboratories, Cardiff, UK), and rinses in gold buffer again. Finally, sections were double stained in uranyl acetate and lead hydroxide.
Results
A large number of nNOS-immunoreactive cells were observed in the epithelium of the corpus and the pyloric region of the mouse, rat and human stomach (Figures 1-3) . These cells, which were more numerous in the pyloric region than in the corpus, displayed the typical features of gastric endocrine cells. They were preferentially located in the lower region of the glands and bore long cytoplasmic processes directed towards the lumen or towards neighboring cells ( Figure 2 ). In the same preparations, some nerve fibers and some ganglion cells of the myenteric plexus were also immunostained for nNOS (Figure 4) . No immunoreactivity was found in rat or mouse forestomach. In the pancreas, strong nNOS immunoreactivity was observed in scattered cells of endocrine islets, which were peripheral in rat and mouse (Figure 5 ) and more randomly distributed in human. The results were the same with the different fixation procedures (Bouin's fluid or paraformaldehyde for paraffinembedded tissue and Zamboni's fixative for resin-embedded tissue).
When the antiserum was preabsorbed with the synthetic peptide, no immunoreactivity was found either in endocrine cells ( Figure  6 ) or in neural tissue. However, the staining remained in a small number of prismatic cells in the gastric surface epithelium. No immunoreactivity was detected in the gastric epithelium or in pancreatic islets with an antiserum specific for inducible NOS.
Different types of gastric endocrine cells were identified with antibodies for gastrin, somatostatin, serotonin, and histamine. By using contiguous sections, we found that nNOS-immunoreactive epithelial cells were also immunoreactive for somatostatin but for none of the other markers tested. Double immunolabeling methods demonstrate even more accurately the co-localization of NOS and somatostatin in the same cells (Figure 7 ). More than 95% of the somatostatin-immunoreactive cells were nNOS-positive, and all nNOS-immunoreactive cells were also positive for somatostatin. The same results were obtained using semithin adjacent sections of resinembedded material in human stomach (Figure 8 ). Pancreatic NOSimmunostained cells were also shown to be immunoreactive for somatostatin.
The possibility of crossreactivity between antisera against nNOS and against somatostatin was eliminated with absorption controls. The immunoreactivity with the antiserum specific to nNOS was not abolished when it was preabsorbed with somatostatin, and the immunoreactivity with anti-somatostatin disappeared when it was preabsorbed with somatostatin but not with the synthetic peptide of the nNOS molecule.
Immunocytochemical techniques using the antiserum against nNOS were also applied to thin sections of human stomach. The immunostaining was found in gastric D-cells, characterized by round, weakly osmiophilic, and relatively large granules (about 200-400 nm) (Figures 9 and 10) . The immunoreactivity was restricted principally to the secretory granules ( Figures 9B and 10B) . No immunoreactivity was detected in other endocrine cell types, such as the gastrin-producing cell shown in Figures 10A and 1OC .
Discussion
In the present work, immunocytochemical localization of neuronal nitric oxide synthase (nNOS) is described in the somatostatinproducing cells of human and murine stomach and pancreas, and the result is confirmed by electron microscopic observations. For our study we have used two different antisera for nNOS.
One is a polyclonal antibody against a specific sequence of nNOS that has been successfully used in previous immunocytochemical studies in different tissues and species (22,23) . Moreover, the spec-ificity of our results is strengthened by the positive and negative controls carried out. The simultaneous immunostaining of ganglion cells in the same histological sections of the stomach and pancreas is a further positive control for the antisera used in our immunocytochemical tests. Absorption controls have also confirmed the specificity of the polyclonal antibody and have enabled us to rule out the possibility of crossreactivity between the antisera against nNOS and that against somatostatin. The fact that all the previous evidence has been consistently obtained in three species (human, rat, and mouse) and using different fixation procedures provides additional support for the co-localization of NOS and somatostatin in both gastric and pancreatic endocrine cells.
Apart from the existence of NO-producing ganglion cells in the neural plexi, in vitro studies have shown that there is also a mucosal source for NO in the mammalian stomach. In rat gastric mucosa, several detection methods have shown that constitutive NOS activity is not restricted to the endothelium of the mucosal microvasculature (11,24). Isolated epithelial cells from the gastric glands, obtained by means of density gradient and elutriation techniques, showed high levels of NOS activity (13). The main cell type present in the elutriation fraction that exhibited maximal levels of NOS activity was the mucus-containing epithelial cells. In contrast, fractions enriched in parietal or chief cells had low NOS activity. On the basis of these findings, it was proposed that the mucous cells were the gastric epithelial cells involved in NO production. Nevertheless, immunocytochemical studies have thus far not confirmed the presence of NOS in the mucosecretory cells of the gastric epithelium. Moreover, in the present study we show a clear immunocytochemical signal for nNOS in the somatostatin endocrine cells of the epithelium, whereas no immunocytochemical label is found either in the mucosecretory or in any other main gastric epithelial cell types. The high levels of NOS ativity detected in the mucous cell fraction could be due to the presence of co-eluted somatostatin cells. According to previous elutriation studies of rat gastric cells, the conditions for collection of somatostatin cells (25) overlap with those for mucosecretory cells.
A previous report by other authors, using a different antiserum, has shown immunocytochemical signal for NOS in the brush cells of the rat gastric cardia (14). We have also obtained immunostaining of scattered prismatic cells with the histological appearance of brush cells in our study, but the positive reaction could not be abolished by preincubation of the antibody with its antigen. Finally, we have not observed the NOS immunoreactivity in the murine forestomach reported by Schmidt et al. (4,33) . In the endocrine cells of pancreatic islets, the presence of NOS is presently a matter of debate. Although Schmidt et al. (34) described NOS immunoreactivity in the majority of rat pancreatic endocrine cells, other studies carried out with other antisera under various fixation conditions were unable to demonstrate specific immunoreactivity for NOS in human and rat islet cells (35-38) . The existence of local NOS isoforms has been proposed to account for such discrepancies.
Our study confirms, although only partially, the finding of immunostaining by Schmidt et al. (34) . In human, rat, and mouse pancreas, strong immunoreactivity for NOS has been obtained in endocrine islet cells, although only in the peripheral, somatostatinimmunoreactive cells, in contrast to the presence of NOS in both peripheral and central islet cells reported by Schmidt et al. (34) .
These authors correlate the existence of NOS in pancreatic B-cells with the stimulation of insulin release by NO produced within the secretory B-cells themselves. However, according to our results, such hypothetic NO-mediated insulin release, if real, would rather take place not through an autocrine mechanism but through a paracrine mechanism from nearby somatostatin cells. Because alterations of the oxidative L-arginine pathway may be one of the mechanisms involved in the pathogenesis of insulin-dependent diabetes mellitus, further morphological, biochemical, and physiological confirmation of our results would be of great interest.
The subcellular localization of NOS is still a matter of discussion. Biochemical studies in neural and endothelial tissues have shown the existence of both cytosolic and membrane-bound forms of the enzyme (34-42). Immunolabeling for NOS has been localized either in the cytoplasmic matrix (4,43,44) or associated with several organelles, including endoplasmic reticulum (44-46), mastcell secretory granules (47). and synaptic vesicles (48) or even with electron-dense material of undetermined nature (49). Our electron microscopic immunocytochemical results show the principal association of NOS with the secretory granules of human gastric somatostatin cells. The presence of NOS in endocrine granules of these cells raises the possibility of activation of the enzyme, and therefore production of NO, together with the exocytosis of the secretory granule content.
The functional role of endogenous NO in the mucosa of the stomach and its possible clinical implications is a matter of current discussion (6). The main effect of endogenous NO within the gastric mucosa appears to be of a protective nature. For example, the protection of rat gastric mucosa against challenge by local irritants under several experimental conditions appears to involve the NO pathway (50-52). The possible protective effects might be achieved by modulation of mucosal blood flow (52.53) or by stimulation of mucous secretion from the epithelial cells, increasing the thickness of the mucous gel that covers the mucosal outer surface (54~5).
The localization of NO synthase in the somatostatin-producing cells is of particular interest from the functional point of view. On the one hand, somatostatin inhibits gastric acid secretion by the parietal cells (56.57). The NO released by somatostatin-containing cells might act in a synergistic protective way by stimulation of nearby mucosecretory cells and by local vasodilatation in neighboring microvessels. The finding of NOS in the somatostatin cells does not preclude other sources for NO within the gastric mucosa, such as the endothelial or muscle cells of the blood vessels. 
